With More Than 100,000 Participants, Partners Biobank Is Meeting Its Research Mission
Within the Partners HealthCare Biobank—a collection of patient blood samples combined with Partners electronic health record data and self-reported family health history—volume yields insights.
Seeing is Believing: Following a Mass. Eye and Ear Therapeutic First
In April, we highlighted a pioneering Mass. Eye and Ear gene therapy treatment offering hope to a young patient with inherited retinal disorder. Though the surgical-first, newly therapeutic called Luxturna had yielded encouraging clinical trial results, there was no way to know for sure how it would impact the young patient’s eyesight—until now.
ALS Clinical Trial Follows Path to New Treatment
Only two drugs have been FDA approved to treat amyotrophic lateral sclerosis (ALS) since 1995. Now, an encouraging new treatment may exist in a phase 3 clinical trial of NurOwn, the first-ever stem cell therapy for ALS developed by BrainStorm Cell Therapeutics. And MGH is one of six national sites testing the therapy in patients.
Fueled by Complexity, Research Yields New Hope for Epilepsy
Ellen J. Bubrick, MD, has never shied from complexity—in fact, that’s what drew the Brigham and Women’s Hospital researcher and epilepsy surgery program director to neurology in the first place. Complexity led Dr. Bubrick to target her research toward helping patients with uncontrolled epilepsy that is unresponsive to conventional treatment.
Home, Safe Home: Benefits of Care Beyond the Hospital
For acutely ill adult patients, does care in the comfort of home deliver the same outcomes as hospital care? That was the essential question of a recent Brigham and Women's Hospital (BWH) pilot study, the first randomized, controlled clinical trial in the nation to test the impact of home-based hospital care on care quality, safety, and costs.
New Executive Director Harnesses the Potential of Partners' Clinical Trials
For patients seeking treatment for a wide range of challenging conditions, Partners HealthCare’s wealth of clinical trials offer access to novel therapies or treatment strategies otherwise unavailable in the normal course of care.